Atlas Trials

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

Clinical trial NCT02664935 · COMPLETED

Trial details

NCT number
NCT02664935
Sponsor
University of Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung CancerCarcinoma, Squamous CellAdenocarcinoma
Start date
2015-05-13
Primary completion
2023-11-29
Enrollment
423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.